Drug Type Small molecule drug |
Synonyms MK 8655 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 1 | - | 19 Sep 2012 |
Phase 1 | 33 | (MK-8655 80 mg/MK-8655 320 mg) | yvqhrntsbx = irdjelemch qgsvtykhyz (wdijdjzxhl, otwqbjhgua - rrmaqtqxhy) View more | - | 13 Nov 2018 | ||
Placebo (Placebo) | yvqhrntsbx = zwswyjenht qgsvtykhyz (wdijdjzxhl, aagojgkycg - klgpnyepzy) View more |





